Acetylcholinesterase Conformational States Influence Nitric Oxide Mobilization in the Erythrocyte

Journal of Membrane Biology

Volumn 248, Issue 2, 2015, Pages 349-354

  Teixeira, Pedro ^a   Duro, Nuno ^a   Napoleão, Patrícia ^a   Saldanha, Carlota ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Acetylcholinesterase; Erythrocyte; Nitric oxide; Protein kinase C

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; MONOCLONAL ANTIBODY; NITRIC OXIDE; PROTEIN KINASE C; S NITROSOGLUTATHIONE;

CHEMISTRY; DRUG EFFECTS; ENZYME ACTIVATION; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; HUMAN; MALE; METABOLISM; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANTIBODIES, MONOCLONAL; ENZYME ACTIVATION; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HUMANS; MALE; NITRIC OXIDE; PROTEIN CONFORMATION; PROTEIN KINASE C; S-NITROSOGLUTATHIONE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84939947134     PISSN: 00222631     EISSN: 14321424     Source Type: Journal    
DOI: 10.1007/s00232-015-9776-y     Document Type: Article

References (34)

1. Almeida JP, Freitas-Santos T, Saldanha C (2009) Fibrinogen-dependent signaling in microvascular erythrocyte function: implications on nitric oxide efflux. J Membr Biol 231(1):47–53. doi:10.1007/s00232-009-9204-2 (Epub 2009 Oct 7)
2. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29(11):1039–1045. doi:10.1038/nbt.2017
3. Bon S, Rosenberry TL, Massoulié J (1991) Amphiphilic, glycophosphatidylinositol-specific phospholipase C (PI-PLC)-insensitive monomers and dimers of acetylcholinesterase. Cell Mol Neurobiol 11(1):157–172
4. Bordin L, Clari G, Moro I, Vecchia FD, Moret V (1995) Functional link between phosphorylation state of membrane proteins and morphological changes of human erythrocytes. Biochem Biophys Res Commun 213(1):249–257
5. Carvalho FA, Martins-Silva J, Saldanha C (2004a) Amperometric measurements of nitric oxide in erythrocytes. Biosens Bioelectron 20(3):505–508
6. Carvalho FA, Mesquita R, Martins-Silva J, Saldanha C (2004b) Acetylcholine and choline effects on erythrocyte nitrite and nitrate levels. J Appl Toxicol 24(6):419–427
7. Carvalho FA, Almeida JP, Fernandes IO, Freitas-Santos T, Saldanha C (2008) Non-neuronal cholinergic system and signal transduction pathways mediated by band 3 in red blood cells. Clin Hemorheol Microcirc 40(3):207–227
8. Carvalho FA, de Almeida JP, Freitas-Santos T, Saldanha C (2009) Modulation of erythrocyte acetylcholinesterase activity and its association with G protein-band 3 interactions. J Membr Biol 228(2):89–97. doi:10.1007/s00232-009-9162-8 (Epub 2009 Mar 18)
9. Cook JA, Kim SY, Teague D, Krishna MC, Pacelli R, Mitchell JB et al (1996) Convenient colorimetric and fluorometric assays for S-nitrosothiols. Anal Biochem 238(2):150–158
10. Cosentino-Gomes D, Rocco-Machado N, Meyer-Fernandes JR (2012) Cell signaling through protein kinase C oxidation and activation. Int J Mol Sci 13:10697–10721
11. Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351(Pt 1):95–105
12. de Oliveira S, Silva-Herdade AS, Saldanha C (2008) Modulation of erythrocyte deformability by PKC activity. Clin Hemorheol Microcirc 39(1–4):363–373
13. Emerit I, Cerutti PA (1981) Tumour promoter phorbol-12-myristate-13-acetate induces chromosomal damage via indirect action. Nature 293(5828):144–146
14. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288(5789):373–376
15. Gould CM, Antal CE, Reyes G, Kunkel MT, Adams RA, Ziyar A, Riveros T, Newton AC (2011) Active site inhibitors protect protein kinase C from dephosphorylation and stabilize its mature form. J Biol Chem 286(33):28922–28930. doi:10.1074/jbc.M111.272526 (Epub 2011 Jun 29)
16. Grisaru D, Sternfeld M, Eldor A, Glick D, Soreq H (1999) Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem 264(3):672–686
17. Herbert JM, Augereau JM, Gleye J, Maffrand JP (1990) Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172(3):993–999
18. Kawashima K, Fujii T (2004) Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci 1(9):2063–2085
19. Khalil RA (2013) Protein kinase C inhibitors as modulators of vascular function and their application in vascular disease. Pharmaceuticals (Basel) 6(3):407–439. doi:10.3390/ph6030407
20. Kizub IV, Klymenko KI, Soloviev AI (2014) Protein kinase C in enhanced vascular tone in diabetes mellitus. Int J Cardiol 174(2):230–242. doi:10.1016/j.ijcard.2014.04.117 (Epub 2014 Apr 18)
21. Lee SK, Qing WG, Mar W, Luyengi L, Mehta RG, Kawanishi K, Fong HH, Beecher CW, Kinghorn AD, Pezzuto JM (1998) Angoline and chelerythrine, benzophenanthridine alkaloids that do not inhibit protein kinase C. J Biol Chem 273(31):19829–19833
22. Lin HW, Gresia VL, Stradecki HM, Alekseyenko A, Dezfulian C, Neumann JT, Dave KR, Perez-Pinzon MA (2014) Protein kinase C delta modulates endothelial nitric oxide synthase after cardiac arrest. J Cereb Blood Flow Metab 34(4):613–620 (Epub 2014 Jan 22)
23. Lopes de Almeida JP, Oliveira S, Saldanha C (2012) Erythrocyte as biological sensor. Clin Hemorheol Microcirc 51(1):1–20. doi:10.3233/CH-2011-1512
24. Massoulié J, Bon S (2006) The C-terminal T peptide of cholinesterases: structure, interactions, and influence on protein folding and secretion. J Mol Neurosci 30(1–2):233–236
25. Mohamed AH, Steck TL (1986) Band 3 tyrosine kinase. Association with the human erythrocyte membrane. Biol Chem 261(6):2804–2809
26. Niday E, Wang CS, Alaupovic P (1980) Kinetic evidence for the allosteric substrate inhibition of human erythrocyte acetylcholinesterase. Biochim Biophys Acta 612(1):67–72
27. 2+-independent calmodulin binding sites in erythrocyte protein 4.1 implications for regulation of protein 4.1 interactions with transmembrane proteins. Biological Chem 275(9):6360–6367
28. Rosse C, Linch M, Kermorgant S, Cameron AJ, Boeckeler K, Parker PJ (2010) PKC and the control of localized signal dynamics. Nat Rev Mol Cell Biol 11:103–112
29. Saldanha C (1985) Contribution to the kinetics study of human erythrocyte acetylcholinesterase. Dissertation, University of Lisbon
30. Ulker P, Gunduz F, Meiselman HJ, Baskurt OK (2013) Nitric oxide generated by red blood cells following exposure to shear stress dilates isolated small mesenteric arteries under hypoxic conditions. Clin Hemorheol Microcirc 54(4):357–369
31. Wessler I, Kirkpatrick CJ, Racké K (1999) The cholinergic ‘pitfall’: acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol 26(3):198–205
32. Wright DL, Plummer DT (1973) Multiple forms of acetylcholinesterase from human erythrocytes. Biochemical 133(3):521–527
33. Yannoukakos D, Vasseur C, Piau JP, Wajcman H, Bursaux E (1991) Phosphorylation sites in human erythrocyte band 3 protein. Biochim et Biophys Acta 1061(2):253–266
34. Zhaowei AI, Cohen CM (1993) Phorbol 12-myristate 13-acetatc-stimulated phosphorylation of erythrocyte membrane skeletal proteins is blocked by calpain inhibitors: possible role of protein kinase M. Biochem J 296(Pt 3):675–683